Ocular Surface Diseases

Ocular Surface Diseases
Dry eye disease (DED) is an important problem for patients and their eye care providers because it can affect daily function, quality of life, vision and the outcomes of cataract and refractive surgery. It is also significant because it is a common condition in populations around the world. Dry eye disease seems to be increasing in response to local alterations already present in the eye, systemic diseases and external factors like poor air quality, high pollution and, even, changes in climate. This affects quality of life causing a disruption of a healthy microenvironment at the ocular surface. Studies investigating the epidemiology of DED report a wide range of prevalence rates, which may be explained in part by the use of different definitions. According to available data, however, as many as 33% to 40% of adults have dry eye symptoms. Importantly, findings of studies evaluating signs of DED (eg., tear film breakup time and tear volume) suggest there are individuals with dry eye who are not aware of their condition. Understanding the risk factors for DED, its possible etiologies, and the pathophysiologic mechanisms by which it develops and progresses can help clinicians as they approach the diagnosis and management of this condition. When evaluating patients for DED, it is also important to consider that other ocular surface diseases with overlapping signs and symptoms can mimic DED, but may coexist with and exacerbate DED. Clearly, unravelling the root causes of DED is required for successful treatment. Lately, there have been exciting developments in terms of understanding the pathophysiology of DED as well as for improving diagnosis and management. In this program, a renowned international faculty of DED experts provide an update on recent and forthcoming advances and share pearls for clinical practice. Download Supplement - click here
Tags: ocular pathology
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...